Carregant...
72 Use of Palivizumab in Canada; Data from the CARESS registry 2005–2017
BACKGROUND: The Canadian Registry of Palivizumab (CARESS) tracks palivizumab utilization and hospitalizations for respiratory illness (RI) and respiratory syncytial virus (RSVH) in high-risk infants, whatever the indication. The decision to administer palivizumab is taken by individual clinicians at...
Guardat en:
| Publicat a: | Paediatr Child Health |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6543371/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/pch/pxz066.071 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|